US Stock MarketDetailed Quotes

Zentalis Pharmaceuticals (ZNTL)

Watchlist
  • 4.050
  • -0.040-0.98%
Close May 15 16:00 ET
  • 4.147
  • +0.097+2.40%
Post 20:01 ET
288.30MMarket Cap-2.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zentalis Pharmaceuticals (ZNTL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-0.98%-32.96M
26.70%-125.25M
22.07%-30.94M
38.78%-26.96M
1.23%-34.71M
37.21%-32.64M
17.79%-170.86M
2.21%-39.7M
-13.91%-44.05M
55.67%-35.14M
Net income from continuing operations
26.78%-35.35M
17.37%-137.06M
25.82%-35.22M
33.54%-26.69M
69.56%-26.87M
-580.87%-48.28M
43.26%-165.87M
22.10%-47.47M
27.70%-40.16M
21.58%-88.28M
Operating gains losses
----
-617.39%-660K
---26K
---103K
----
----
-100.56%-92K
--0
--0
-99.61%53K
Depreciation and amortization
-42.37%151K
-42.67%739K
-50.47%157K
-50.16%160K
-51.07%160K
-19.14%262K
-7.20%1.29M
-5.93%317K
-7.76%321K
-4.94%327K
Deferred tax
----
--0
----
----
----
----
--0
--0
--0
--0
Other non cash items
----
----
----
----
----
----
-415.22%-47.43M
---21.87M
--0
--0
Change In working capital
-141.51%-728K
44.85%-9.12M
80.53%-1.38M
83.88%-1.17M
-162.49%-8.33M
111.29%1.75M
-382.06%-16.54M
-168.91%-7.08M
-251.87%-7.26M
358.08%13.33M
-Change in receivables
--0
200.00%5M
--0
--0
--0
--5M
---5M
---5M
--0
--0
-Change in prepaid assets
46.76%973K
-51.87%2.99M
-406.14%-698K
-87.52%679K
46.26%2.35M
162.78%663K
209.51%6.22M
147.60%228K
526.00%5.44M
259.80%1.61M
-Change in payables and accrued expense
63.93%-1.45M
3.92%-17.32M
71.39%-733K
83.54%-1.98M
-189.72%-10.58M
73.62%-4.02M
-265.05%-18.02M
-124.64%-2.56M
-289.79%-12.01M
368.48%11.8M
-Change in other working capital
-319.30%-250K
-23.86%201K
-79.46%53K
118.41%127K
-22.37%-93K
-85.23%114K
-57.62%264K
-26.29%258K
-154.61%-690K
-132.34%-76K
Cash from discontinued investing activities
Operating cash flow
-0.98%-32.96M
26.70%-125.25M
22.07%-30.94M
38.78%-26.96M
1.23%-34.71M
37.21%-32.64M
17.79%-170.86M
2.21%-39.7M
-13.91%-44.05M
55.67%-35.14M
Investing cash flow
Cash flow from continuing investing activities
-25.85%30.01M
-25.45%131.62M
0.51%32.45M
-41.30%28.32M
-11.92%30.38M
-34.24%40.48M
497.14%176.56M
176.75%32.28M
141.08%48.24M
-52.71%34.49M
Net PPE purchase and sale
-780.00%-34K
547.44%698K
--129K
--0
586.21%564K
112.50%5K
73.24%-156K
--0
--0
63.64%-116K
Net investment purchase and sale
-25.75%30.05M
-25.91%130.93M
0.11%32.32M
-41.30%28.32M
-13.85%29.81M
-34.29%40.47M
502.77%176.72M
177.07%32.28M
141.11%48.24M
-52.76%34.61M
Cash from discontinued investing activities
Investing cash flow
-25.85%30.01M
-25.45%131.62M
0.51%32.45M
-41.30%28.32M
-11.92%30.38M
-34.24%40.48M
497.14%176.56M
176.75%32.28M
141.08%48.24M
-52.71%34.49M
Financing cash flow
Cash flow from continuing financing activities
-694.18%-1.12M
-4,064.81%-4.28M
-4.59M
25.00%115K
0
2,600.00%189K
-99.95%108K
0
-70.23%92K
-100.00%9K
Net common stock issuance
75.13%331K
-1,326.93%-4.28M
---4.59M
25.00%115K
--0
-23.79%189K
-99.85%349K
--0
-70.23%92K
-100.00%9K
Net other financing activities
---1.45M
----
----
----
----
----
---241K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-694.18%-1.12M
-4,064.81%-4.28M
---4.59M
25.00%115K
--0
2,600.00%189K
-99.95%108K
--0
-70.23%92K
-100.00%9K
Net cash flow
Beginning cash position
5.73%38.62M
18.91%36.53M
-5.12%41.7M
1.43%40.23M
10.57%44.56M
18.91%36.53M
-32.78%30.72M
-61.24%43.95M
-85.27%39.66M
3.57%40.3M
Current changes in cash
-150.64%-4.07M
-63.95%2.09M
58.53%-3.08M
-65.66%1.47M
-576.56%-4.33M
-16.18%8.03M
138.79%5.81M
91.02%-7.42M
102.75%4.29M
-100.28%-640K
End cash Position
-22.44%34.56M
5.73%38.62M
5.73%38.62M
-5.12%41.7M
1.43%40.23M
10.57%44.56M
18.91%36.53M
18.91%36.53M
-61.24%43.95M
-85.27%39.66M
Free cash flow
-1.08%-32.99M
26.79%-125.25M
22.07%-30.94M
38.78%-26.96M
1.73%-34.71M
37.26%-32.64M
17.91%-171.08M
2.62%-39.7M
-13.65%-44.05M
55.62%-35.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -0.98%-32.96M26.70%-125.25M22.07%-30.94M38.78%-26.96M1.23%-34.71M37.21%-32.64M17.79%-170.86M2.21%-39.7M-13.91%-44.05M55.67%-35.14M
Net income from continuing operations 26.78%-35.35M17.37%-137.06M25.82%-35.22M33.54%-26.69M69.56%-26.87M-580.87%-48.28M43.26%-165.87M22.10%-47.47M27.70%-40.16M21.58%-88.28M
Operating gains losses -----617.39%-660K---26K---103K---------100.56%-92K--0--0-99.61%53K
Depreciation and amortization -42.37%151K-42.67%739K-50.47%157K-50.16%160K-51.07%160K-19.14%262K-7.20%1.29M-5.93%317K-7.76%321K-4.94%327K
Deferred tax ------0------------------0--0--0--0
Other non cash items -------------------------415.22%-47.43M---21.87M--0--0
Change In working capital -141.51%-728K44.85%-9.12M80.53%-1.38M83.88%-1.17M-162.49%-8.33M111.29%1.75M-382.06%-16.54M-168.91%-7.08M-251.87%-7.26M358.08%13.33M
-Change in receivables --0200.00%5M--0--0--0--5M---5M---5M--0--0
-Change in prepaid assets 46.76%973K-51.87%2.99M-406.14%-698K-87.52%679K46.26%2.35M162.78%663K209.51%6.22M147.60%228K526.00%5.44M259.80%1.61M
-Change in payables and accrued expense 63.93%-1.45M3.92%-17.32M71.39%-733K83.54%-1.98M-189.72%-10.58M73.62%-4.02M-265.05%-18.02M-124.64%-2.56M-289.79%-12.01M368.48%11.8M
-Change in other working capital -319.30%-250K-23.86%201K-79.46%53K118.41%127K-22.37%-93K-85.23%114K-57.62%264K-26.29%258K-154.61%-690K-132.34%-76K
Cash from discontinued investing activities
Operating cash flow -0.98%-32.96M26.70%-125.25M22.07%-30.94M38.78%-26.96M1.23%-34.71M37.21%-32.64M17.79%-170.86M2.21%-39.7M-13.91%-44.05M55.67%-35.14M
Investing cash flow
Cash flow from continuing investing activities -25.85%30.01M-25.45%131.62M0.51%32.45M-41.30%28.32M-11.92%30.38M-34.24%40.48M497.14%176.56M176.75%32.28M141.08%48.24M-52.71%34.49M
Net PPE purchase and sale -780.00%-34K547.44%698K--129K--0586.21%564K112.50%5K73.24%-156K--0--063.64%-116K
Net investment purchase and sale -25.75%30.05M-25.91%130.93M0.11%32.32M-41.30%28.32M-13.85%29.81M-34.29%40.47M502.77%176.72M177.07%32.28M141.11%48.24M-52.76%34.61M
Cash from discontinued investing activities
Investing cash flow -25.85%30.01M-25.45%131.62M0.51%32.45M-41.30%28.32M-11.92%30.38M-34.24%40.48M497.14%176.56M176.75%32.28M141.08%48.24M-52.71%34.49M
Financing cash flow
Cash flow from continuing financing activities -694.18%-1.12M-4,064.81%-4.28M-4.59M25.00%115K02,600.00%189K-99.95%108K0-70.23%92K-100.00%9K
Net common stock issuance 75.13%331K-1,326.93%-4.28M---4.59M25.00%115K--0-23.79%189K-99.85%349K--0-70.23%92K-100.00%9K
Net other financing activities ---1.45M-----------------------241K--0--0--0
Cash from discontinued financing activities
Financing cash flow -694.18%-1.12M-4,064.81%-4.28M---4.59M25.00%115K--02,600.00%189K-99.95%108K--0-70.23%92K-100.00%9K
Net cash flow
Beginning cash position 5.73%38.62M18.91%36.53M-5.12%41.7M1.43%40.23M10.57%44.56M18.91%36.53M-32.78%30.72M-61.24%43.95M-85.27%39.66M3.57%40.3M
Current changes in cash -150.64%-4.07M-63.95%2.09M58.53%-3.08M-65.66%1.47M-576.56%-4.33M-16.18%8.03M138.79%5.81M91.02%-7.42M102.75%4.29M-100.28%-640K
End cash Position -22.44%34.56M5.73%38.62M5.73%38.62M-5.12%41.7M1.43%40.23M10.57%44.56M18.91%36.53M18.91%36.53M-61.24%43.95M-85.27%39.66M
Free cash flow -1.08%-32.99M26.79%-125.25M22.07%-30.94M38.78%-26.96M1.73%-34.71M37.26%-32.64M17.91%-171.08M2.62%-39.7M-13.65%-44.05M55.62%-35.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -